Floris Wolswijk

Psychedelic Research Recap April 2025

In April 2025, psychedelic researchers published 172 studies and we’ve added 17 new papers to the database. This month featured ketamine for smoking cessation, HPPD after psychedelic use, effects of DMT on TRD, and much more.

Psychedelic Landscape – Request for Feedback

For the past six years, Blossom has tracked all psychedelic research and distilled the findings for researchers, clinicians and the curious. Along the way, we noticed a glaring gap: knowing what the science says is only half the story—understanding who can turn that science into real-world impact is the other half. Today, we are closing …

Read more

Psychedelic Research Recap March 2025

In March 2025, psychedelic researchers published 138 studies and we’ve added 11 new papers to the database. This month featured psilocybin for alcoholism (AUD), microdosing for ADHD, long-term follow-up, and several investigations into how psychedelics work.

Psychedelic Research Recap February 2025

In February 2025, psychedelic research continued with 11 new studies and 193 linked studies. This month featured investigations into therapeutic applications for alcohol use disorder, pharmacological interactions, brain connectivity changes, visual perception effects, and the emotional dimensions of psychedelic experiences.

Psychedelic Research Recap January 2025

In January 2025, psychedelic research saw modest activity, contributing 11 new studies and 183 linked studies. This month’s additions include clinical trial results, real-world implementation studies, and analyses that further our understanding of these innovative treatments.

Psychedelic Research Recap November 2024

In the November recap, we explore the neuroplasticity mechanisms of psychedelics, their therapeutic applications for mental health conditions like OCD and fibromyalgia, safety considerations, and the significant role of user experiences in therapeutic outcomes.